To date, several biomarkers including NT-proBNP and troponin were reported to predict cardiovascular complications after AMI; nevertheless, whether these biomarkers predict future HF in patients after AMI is unclear, and their use is limited by the heterogeneity of genetic backgrounds, environment, biological behavior, and other diseases [20]. Here, NPPB is linked to hydrops fetalis.